Peter Frampton Says He Likes the ‘Challenge’ of Continuing to Play as His Neuromuscular Disease ‘Progresses’ (Exclusive)
NEED TO KNOW Peter Frampton continues to make music and tour despite living with inclusion body myositis, a…
What’s the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
Investors are always on the lookout for the next revolutionary technology or product. In recent times, this has…
Girl, 9, Becomes Different Person Overnight, Mom Fights For Rare Diagnosis
Lacy was an outgoing, fun nine-year-old. Then, one night, everything changed. She became a shell of herself. Her…
Patient-reported characteristics of pernicious anaemia: a first step to initiate James Lind Alliance Priority Setting Partnership driven research | BMC Primary Care
In response to the publication of ten research priorities related to the cause, diagnosis, management, and treatment of…
Why C3.ai (AI) Stock Is Trading Lower Today
Shares of artificial intelligence (AI) software company C3.ai (NYSE:AI) fell 10% in the afternoon session after the company…